Moving beyond the rebate debate to meaningfully and effectively lower prescription drug costs
Drug prices, not rebates, are the root of the problem
Read MoreWhen the COVID-19 and Obesity Pandemics Collide
The COVID-19 pandemic has accelerated rising rates of obesity.
Read MoreWhat impact will the Inflation Reduction Act have on health plans?
Plan sponsors should be aware of the effects the law will have on Medicare Part D over the coming years.
Read MoreThe Pharmacy Benefit Management Team: Helping Patients Access Affordable Prescription Drugs Safely and Efficiently
Pharmacy benefit managers (PBMs) like Express Scripts are uniquely positioned to help patients in numerous ways.
Read MoreWhat’s on the horizon for nonalcoholic steatohepatitis (NASH) treatment?
The future of NASH treatment is more promising than ever with improved methods for diagnosis and new drugs in development.
Read MoreThree Ways to Optimize a Pharmacy Network
A well-designed pharmacy network strategy offers the right in-network pharmacy coverage to account for population size, geographic area, clinical goals, and utilization patterns.
Read MoreKeeping member health on track: A snapshot of the PBM’s clinical expertise
Express Scripts is helping patients understand and manage their conditions through comprehensive disease management.
Read MoreHow Value-based Solutions Can Improve Costs and Health Outcomes for Chronic Conditions
Over 125 million Americans suffer from chronic conditions, costing the U.S. over $3.4 trillion annually. This topic was the focus of a breakout session at Outcomes+ 2022.
Read MoreGLP-1s Medications 101
GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population in the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-r...
Read MoreGLP-1s and digital support: A winning combination
When GLP-1s aren’t enough, lifestyle modification can be key to weight management.
Read More